Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.
Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.
